Immediate Impact

1 by Nobel laureates 5 from Science/Nature 93 standout
Sub-graph 1 of 23

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Ulcerative colitis
2023 Standout
4 intermediate papers

Works of Joel C. Silverfield being referenced

THU0185 Tofacitinib, An Oral JAK Inhibitor, in The Treatment of Rheumatoid Arthritis: Safety and Clinical and Radiographic Efficacy in Open-Label, Long-Term Extension Studies over 7 Years
2016
Safety and Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Rheumatoid Arthritis in Open-label, Longterm Extension Studies
2014
and 1 more

Author Peers

Author Last Decade Papers Cites
Joel C. Silverfield 537 173 110 247 13 976
Heikki Isomäki 559 191 39 184 15 1.1k
Christine E. Codding 601 498 51 266 9 1.1k
Z Domljan 652 296 40 299 18 1.1k
G H Kingsley 459 267 44 175 16 917
Allison Smitten 552 128 36 210 9 1.0k
José Ramón Maneiro 716 339 28 228 28 1.0k
Agnes L. Maier 624 281 41 356 22 1.1k
Maher Issa 477 118 27 178 26 917
Moraye B. Bear 413 207 31 249 16 1.1k
Eva Salgado 492 253 26 139 22 786

All Works

Loading papers...

Rankless by CCL
2026